Milan, Italy

Renato Molteni

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Renato Molteni: Innovator in Pharmaceutical Production**

Introduction

Renato Molteni, an accomplished inventor based in Milan, Italy, has made significant contributions to the pharmaceutical industry through his innovative approaches. With a total of 3 patents to his name, Molteni focuses on the development of key compounds beneficial for various medical conditions, showcasing his expertise and dedication to improving patient care.

Latest Patents

Renato Molteni's latest patents include a groundbreaking process for the production of glycopyrronium tosylate. This work provides methods for the synthesis of glycopyrronium tosylate compositions, which are crucial for the treatment of hyperhidrosis and other conditions. His patents detail not only the methods of production but also highlight compositions that facilitate the manufacturing process of glycopyrronium tosylate, emphasizing his role as a pioneer in this field.

Career Highlights

Throughout his career, Molteni has worked with notable companies such as Dermira, Inc. and Journey Medical Corporation. His experiences in these reputable organizations have equipped him with the skills and insights necessary to drive innovations in pharmaceutical production. His entrepreneurial spirit and commitment to excellence make him a prominent figure in the landscape of medical innovations.

Collaborations

Renato Molteni has collaborated with distinguished professionals, including Anthony Adrian Shaw and Enrico Vigano. These partnerships have played a vital role in advancing his research and development efforts, fostering an environment of innovation that benefits the medical community.

Conclusion

In summary, Renato Molteni stands out as a vital contributor to the field of pharmaceuticals. His dedication to the production of glycopyrronium tosylate underscores his innovation and commitment to enhancing therapeutic options for patients. With his continued efforts, Molteni is poised to leave a lasting impact on the industry, inspiring future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…